PortfoliosLab logo
COO vs. LMAT
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between COO and LMAT is 0.27, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Performance

COO vs. LMAT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in The Cooper Companies, Inc. (COO) and LeMaitre Vascular, Inc. (LMAT). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Sharpe Ratio

COO:

-0.76

LMAT:

0.15

Sortino Ratio

COO:

-1.00

LMAT:

0.36

Omega Ratio

COO:

0.86

LMAT:

1.05

Calmar Ratio

COO:

-0.64

LMAT:

0.12

Martin Ratio

COO:

-1.58

LMAT:

0.27

Ulcer Index

COO:

16.16%

LMAT:

12.49%

Daily Std Dev

COO:

32.23%

LMAT:

35.16%

Max Drawdown

COO:

-98.75%

LMAT:

-75.69%

Current Drawdown

COO:

-40.07%

LMAT:

-23.50%

Fundamentals

Market Cap

COO:

$13.65B

LMAT:

$1.86B

EPS

COO:

$2.07

LMAT:

$1.97

PE Ratio

COO:

32.99

LMAT:

41.73

PEG Ratio

COO:

1.17

LMAT:

2.15

PS Ratio

COO:

3.42

LMAT:

8.21

PB Ratio

COO:

1.65

LMAT:

5.34

Total Revenue (TTM)

COO:

$2.99B

LMAT:

$226.26M

Gross Profit (TTM)

COO:

$1.95B

LMAT:

$155.66M

EBITDA (TTM)

COO:

$661.60M

LMAT:

$61.61M

Returns By Period

In the year-to-date period, COO achieves a -25.73% return, which is significantly lower than LMAT's -10.35% return. Over the past 10 years, COO has underperformed LMAT with an annualized return of 4.15%, while LMAT has yielded a comparatively higher 24.14% annualized return.


COO

YTD

-25.73%

1M

-17.04%

6M

-34.64%

1Y

-27.60%

3Y*

-7.99%

5Y*

-2.92%

10Y*

4.15%

LMAT

YTD

-10.35%

1M

4.70%

6M

-22.80%

1Y

5.08%

3Y*

22.74%

5Y*

26.24%

10Y*

24.14%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


The Cooper Companies, Inc.

LeMaitre Vascular, Inc.

Go deeper with the Portfolio Analysis tool — backtest performance, assess risk, compare to benchmarks, and more

Risk-Adjusted Performance

COO vs. LMAT — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

COO
The Risk-Adjusted Performance Rank of COO is 1010
Overall Rank
The Sharpe Ratio Rank of COO is 1111
Sharpe Ratio Rank
The Sortino Ratio Rank of COO is 1212
Sortino Ratio Rank
The Omega Ratio Rank of COO is 1111
Omega Ratio Rank
The Calmar Ratio Rank of COO is 1111
Calmar Ratio Rank
The Martin Ratio Rank of COO is 44
Martin Ratio Rank

LMAT
The Risk-Adjusted Performance Rank of LMAT is 5353
Overall Rank
The Sharpe Ratio Rank of LMAT is 5757
Sharpe Ratio Rank
The Sortino Ratio Rank of LMAT is 4747
Sortino Ratio Rank
The Omega Ratio Rank of LMAT is 4747
Omega Ratio Rank
The Calmar Ratio Rank of LMAT is 5858
Calmar Ratio Rank
The Martin Ratio Rank of LMAT is 5555
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

COO vs. LMAT - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for The Cooper Companies, Inc. (COO) and LeMaitre Vascular, Inc. (LMAT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The current COO Sharpe Ratio is -0.76, which is lower than the LMAT Sharpe Ratio of 0.15. The chart below compares the historical Sharpe Ratios of COO and LMAT, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading data...

Go to the full Sharpe Ratio tool to analyze any stock or portfolio. Customize time frames, set your own risk-free rate, and more

Dividends

COO vs. LMAT - Dividend Comparison

COO has not paid dividends to shareholders, while LMAT's dividend yield for the trailing twelve months is around 0.88%.


TTM20242023202220212020201920182017201620152014
COO
The Cooper Companies, Inc.
0.00%0.00%0.02%0.02%0.01%0.02%0.02%0.02%0.03%0.03%0.04%0.04%
LMAT
LeMaitre Vascular, Inc.
0.88%0.69%0.99%1.09%0.88%0.94%0.95%1.18%0.69%0.71%0.93%1.83%

Drawdowns

COO vs. LMAT - Drawdown Comparison

The maximum COO drawdown since its inception was -98.75%, which is greater than LMAT's maximum drawdown of -75.69%. Use the drawdown chart below to compare losses from any high point for COO and LMAT.


Loading data...

Go to the full Drawdowns tool for more analysis options, including inflation-adjusted drawdowns, and more

Volatility

COO vs. LMAT - Volatility Comparison

The Cooper Companies, Inc. (COO) has a higher volatility of 17.24% compared to LeMaitre Vascular, Inc. (LMAT) at 16.24%. This indicates that COO's price experiences larger fluctuations and is considered to be riskier than LMAT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading data...

Financials

COO vs. LMAT - Financials Comparison

This section allows you to compare key financial metrics between The Cooper Companies, Inc. and LeMaitre Vascular, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00200.00M400.00M600.00M800.00M1.00BJulyOctober2021AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025
964.70M
59.87M
(COO) Total Revenue
(LMAT) Total Revenue
Values in USD except per share items

COO vs. LMAT - Profitability Comparison

The chart below illustrates the profitability comparison between The Cooper Companies, Inc. and LeMaitre Vascular, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

62.0%64.0%66.0%68.0%70.0%JulyOctober2021AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025
68.4%
69.2%
(COO) Gross Margin
(LMAT) Gross Margin
COO - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2025, The Cooper Companies, Inc. reported a gross profit of 660.20M and revenue of 964.70M. Therefore, the gross margin over that period was 68.4%.

LMAT - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2025, LeMaitre Vascular, Inc. reported a gross profit of 41.42M and revenue of 59.87M. Therefore, the gross margin over that period was 69.2%.

COO - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2025, The Cooper Companies, Inc. reported an operating income of 182.00M and revenue of 964.70M, resulting in an operating margin of 18.9%.

LMAT - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2025, LeMaitre Vascular, Inc. reported an operating income of 12.63M and revenue of 59.87M, resulting in an operating margin of 21.1%.

COO - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2025, The Cooper Companies, Inc. reported a net income of 104.30M and revenue of 964.70M, resulting in a net margin of 10.8%.

LMAT - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2025, LeMaitre Vascular, Inc. reported a net income of 11.01M and revenue of 59.87M, resulting in a net margin of 18.4%.